TMDX
TransMedics Group, Inc.
$71.14
+2.46%
$2.6B
No data for this timeframe.
Vol
Market Cap$2.6B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (74%)
Inst. Holders9 funds
Inst. Value$1.3B
Inst. Activity2 buys / 2 sells
Insider Activity0B / 2S
Insider Net $-$298.7K
Reddit Sentiment67° Warm
SEC Reports4
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. MA·CIK 0001756262·Prev Close $69.43
Recent Activity
Jun 9, 2026
short_volume
Short Volume: TMDX — 64.9% short (0.4M / 0.6M)
Short: 368,462 | Exempt: 120 | TRF Vol: 567,468 | Short Ratio: 64.9% | Off-exchange volume (dark poo
May 20, 2026
Insider
Basile Edward M sold 2,922 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
TOBIN JAMES R sold 2,922 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
Kania Edwin sold 2,922 shares
Director @ $0.00 ($0.00)
Apr 10, 2026
SEC
TransMedics Group, Inc. is holding its 2026 Annual Meeting, where shareholders will vote on director elections, executiv
DEFA14A — Impact 3/10
Mar 6, 2026
SEC
Two TransMedics insiders conducted open-market share sales within the past week, totaling approximately $299,000 in proc
CLUSTER — Impact 3/10
Feb 27, 2026
SEC
TransMedics provided additional details on its Q4 2025 financial results, clarifying that the previously reported $105.4
8-K — Impact 4/10
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
435,969 shares ($53.0M)
Price Targets
$116.78
+57.2% upside
Strong Buy
Current $74.29
Low $75.00
Median $120.00
High $142.00
9 analysts
$75.00
$142.00
Analyst Ratings
5Strong Buy
9Buy
5Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 26, 2026 | Stifel | MAINTAIN | Hold → Hold |
| May 6, 2026 | Canaccord Genuity | MAINTAIN | Buy → Buy |
| May 6, 2026 | TD Cowen | MAINTAIN | Buy → Buy |
| May 6, 2026 | Stifel | MAINTAIN | Hold → Hold |
| May 6, 2026 | Piper Sandler | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.55 ▼ -9.8% | $0.47 — $0.67 | -40% YoY | 7 |
| Next Q | $0.47 ▲ +5.9% | $0.28 — $0.61 | -29% YoY | 8 |
| Current FY | $2.05 ▼ -5.6% | $1.63 — $2.41 | -22% YoY | 8 |
| Next FY | $3.30 ▼ -7.3% | $2.40 — $4.25 | 61% YoY | 7 |
Latest Reports
NEUTRAL
DEFA14A
3/10
TransMedics Group, Inc. is holding its 2026 Annual Meeting, where shareholders will vote on director elections, executiv
Apr 10, 2026
NEUTRAL
CLUSTER
3/10
Two TransMedics insiders conducted open-market share sales within the past week, totaling approximately $299,000 in proc
Mar 6, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| FMR LLC | $617.6M | — |
| VANGUARD GROUP INC | $438.6M | — |
| MORGAN STANLEY | $81.2M | TRIM |
| TWO SIGMA INVESTMENTS, LP | $53.0M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $39.3M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Basile Edward | A | $0.00 |
| May 20, 2026 | TOBIN JAMES | A | $0.00 |
| May 20, 2026 | Kania Edwin | A | $0.00 |
| May 20, 2026 | RAINES MERILEE | A | $0.00 |
| May 20, 2026 | Gunderson Thomas | A | $0.00 |
Reddit Sentiment
67°
Warm
Bearish
Neutral
Bullish
9 institutional holders with $1.3B total value (10,687,797 shares) as of 2025-Q4. Top holders: FMR, VANGUARD, MORGAN.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | FMR LLC | 5,077,036 | $617.6M | 47.5% | — |
| 2 | VANGUARD GROUP INC | 3,605,279 | $438.6M | 33.7% | — |
| 3 | MORGAN STANLEY | 667,761 | $81.2M | 6.2% | TRIM -25.2% |
| 4 | TWO SIGMA INVESTMENTS, LP | 435,969 | $53.0M | 4.1% | TRIM -31.4% |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 323,026 | $39.3M | 3.0% | NEW |
| 6 | BANK OF AMERICA CORP /DE/ | 279,303 | $34.0M | 2.6% | ADD +29.3% |
| 7 | WELLS FARGO & COMPANY/MN | 258,550 | $31.5M | 2.4% | ADD +25.8% |
| 8 | NORGES BANK | 30,574 | $3.7M | 0.3% | NEW |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 10,299 | $1.3M | 0.1% | NEAR_EXIT -92.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | TRIM | 635,394 | 435,969 | -31.4% | $53.0M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 215,975 | 279,303 | +29.3% | $34.0M | 2025-Q4 |
| NORGES BANK | NEW | — | 30,574 | — | $3.7M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 145,199 | 10,299 | -92.9% | $1.3M | 2025-Q4 |
| UBS Group AG | ADD | 476,138 | 856,063 | +79.8% | $96.1M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 411,985 | 635,394 | +54.2% | $71.3M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 732,808 | 547,819 | -25.2% | $61.5M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 145,199 | — | $16.3M | 2025-Q3 |
| NORGES BANK | EXIT | 40,274 | 0 | -100.0% | $0.00 | 2025-Q3 |
| UBS Group AG | TRIM | 741,335 | 476,138 | -35.8% | $63.8M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 22,705 | 411,985 | +1714.5% | $55.2M | 2025-Q2 |
| NORGES BANK | NEW | — | 40,274 | — | $5.4M | 2025-Q2 |
| CITADEL ADVISORS LLC | ADD | 775,734 | 1,172,589 | +51.2% | $78.9M | 2025-Q1 |
| UBS Group AG | ADD | 590,242 | 741,335 | +25.6% | $49.9M | 2025-Q1 |
| MORGAN STANLEY | ADD | 454,438 | 599,060 | +31.8% | $40.3M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | ADD | 169,478 | 213,270 | +25.8% | $14.3M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | ADD | 12,523 | 22,705 | +81.3% | $1.5M | 2025-Q1 |
| NORGES BANK | EXIT | 366,661 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 295,300 | 775,734 | +162.7% | $48.4M | 2024-Q4 |
| UBS Group AG | DOUBLED | 59,252 | 590,242 | +896.2% | $36.8M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 111,799 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 271,694 | — | $42.7M | 2024-Q3 |
10 unique insiders with 2 transactions. Net insider value: -$298.7K ($0.00 bought, $298.7K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Basile Edward M | Director | A | 2,922 | $0.00 | $0.00 |
| May 20, 2026 | TOBIN JAMES R | Director | A | 2,922 | $0.00 | $0.00 |
| May 20, 2026 | Kania Edwin | Director | A | 2,922 | $0.00 | $0.00 |
| May 20, 2026 | RAINES MERILEE | Director | A | 2,922 | $0.00 | $0.00 |
| May 20, 2026 | Gunderson Thomas J. | Director | A | 2,922 | $0.00 | $0.00 |
| May 20, 2026 | Weill David | Director | A | 2,922 | $0.00 | $0.00 |
| May 20, 2026 | Lovell Stephanie | Director | A | 2,922 | $0.00 | $0.00 |
| May 19, 2026 | Forsyth Matthew S. | See Remarks | A | 15,409 | $0.00 | $0.00 |
| May 19, 2026 | Forsyth Matthew S. | See Remarks | A | 23,171 | $0.00 | $0.00 |
| Mar 4, 2026 | Weill David | Director | M | 3,571 | $14.20 | $50.7K |
| Mar 4, 2026 | Lovell Stephanie | Director | SELL | 1,193 | $149.62 | $178.5K |
| Mar 4, 2026 | Weill David | Director | M | 3,571 | $0.00 | $0.00 |
| Mar 2, 2026 | Ranganath Anil P. | See remarks | SELL | 864 | $139.12 | $120.2K |
| Feb 18, 2026 | Cecere Giovanni | Chief Commercial Officer | A | 11,082 | $0.00 | $0.00 |
| Feb 18, 2026 | Cecere Giovanni | Chief Commercial Officer | A | 16,734 | $0.00 | $0.00 |
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.5/10.
NEUTRAL
DEFA14A
3/10
TransMedics Group, Inc. is holding its 2026 Annual Meeting, where shareholders will vote on director
Apr 10, 2026
NEUTRAL
CLUSTER
3/10
Two TransMedics insiders conducted open-market share sales within the past week, totaling approximat
Mar 6, 2026
NEUTRAL
8-K
4/10
TransMedics provided additional details on its Q4 2025 financial results, clarifying that the previo
Feb 27, 2026
BULLISH
8-K
8/10
TransMedics reported strong fourth quarter and full year 2025 financial results, with revenue up 32%
Feb 24, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (74% buy). Based on 19 analysts: 5 strong buy, 9 buy, 5 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$116.78 mean target
+57.2% upside
Strong Buy (1.73)
$75.00 Low
$142.00 High
| Metric | Value |
|---|---|
| Current Price | $74.29 |
| Target Low | $75.00 |
| Target Mean | $116.78 |
| Target Median | $120.00 |
| Target High | $142.00 |
| # Analysts | 9 |
| Recommendation | Strong Buy (1.73) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.55 | $0.47 | $0.67 | -40.4% | -9.8% | 1↑ 3↓ | $0.2B | 16.9% | 7 |
| Next Q 2026-09-30 |
$0.47 | $0.28 | $0.61 | -28.6% | +5.9% | 1↑ 3↓ | $0.2B | 22.3% | 8 |
| Current FY 2026-12-31 |
$2.05 | $1.63 | $2.41 | -22.1% | -5.6% | 2↑ 5↓ | $0.7B | 21.0% | 8 |
| Next FY 2027-12-31 |
$3.30 | $2.40 | $4.25 | 61.1% | -7.3% | 3↑ 3↓ | $0.9B | 18.5% | 7 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.548 | |
| 7d ago | $0.606 | -0.058 |
| 30d ago | $0.608 | -0.060 |
| 60d ago | $0.746 | -0.198 |
| 90d ago | $0.777 | -0.228 |
8 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 26, 2026 | Stifel | MAINTAIN | Hold | Hold |
| May 6, 2026 | Canaccord Genuity | MAINTAIN | Buy | Buy |
| May 6, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| May 6, 2026 | Stifel | MAINTAIN | Hold | Hold |
| May 6, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| May 6, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 9, 2026 | Stifel | MAINTAIN | Hold | Hold |
| Feb 25, 2026 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Feb 25, 2026 | Oppenheimer | MAINTAIN | Outperform | Outperform |
| Feb 25, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Feb 25, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 25, 2026 | Needham | MAINTAIN | Buy | Buy |
| Dec 17, 2025 | Canaccord Genuity | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 9 | 5 | 0 | 0 | 74% | |
| May 1, 2026 | 7 | 9 | 4 | 0 | 0 | 80% | |
| Apr 1, 2026 | 7 | 9 | 4 | 0 | 0 | 80% | |
| Mar 1, 2026 | 7 | 9 | 4 | 0 | 0 | 80% | |
| Feb 1, 2026 | 7 | 9 | 4 | 0 | 0 | 80% | |
| Jan 1, 2026 | 7 | 9 | 4 | 0 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
67°
Warm
Bearish
Neutral
Bullish
2 mentions
2 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 21, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 21, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
$154k yolo into $TMDX
▲ 1
💬 1
⚡ 0.5
Jun 9, 2026
short_volume
Short Volume: TMDX — 64.9% short (0.4M / 0.6M)
Short: 368,462 | Exempt: 120 | TRF Vol: 567,468 | Short Ratio: 64.9% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: TMDX — 61.6% short (0.3M / 0.5M)
Short: 316,835 | Exempt: 57 | TRF Vol: 514,106 | Short Ratio: 61.6% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: TMDX — 69.9% short (0.4M / 0.6M)
Short: 411,524 | Exempt: 602 | TRF Vol: 588,514 | Short Ratio: 69.9% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: TMDX — 57.3% short (0.3M / 0.6M)
Short: 330,998 | Exempt: 118 | TRF Vol: 577,296 | Short Ratio: 57.3% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: TMDX — 64.3% short (0.4M / 0.6M)
Short: 365,538 | Exempt: 3,309 | TRF Vol: 568,460 | Short Ratio: 64.3% | Off-exchange volume (dark pool + OTC)
May 27, 2026
short_volume
Short Volume: TMDX — 70.8% short (0.5M / 0.7M)
Short: 495,363 | Exempt: 1 | TRF Vol: 700,109 | Short Ratio: 70.8% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: TMDX — 80.3% short (0.6M / 0.7M)
Short: 577,894 | Exempt: 88 | TRF Vol: 719,893 | Short Ratio: 80.3% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: TMDX — 61.1% short (0.4M / 0.6M)
Short: 385,058 | Exempt: 0 | TRF Vol: 629,731 | Short Ratio: 61.1% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: TMDX — 72.0% short (0.4M / 0.5M)
Short: 363,542 | Exempt: 116 | TRF Vol: 504,598 | Short Ratio: 72.0% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: TMDX — 72.7% short (0.4M / 0.5M)
Short: 390,810 | Exempt: 0 | TRF Vol: 537,583 | Short Ratio: 72.7% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: TMDX — 74.5% short (0.5M / 0.7M)
Short: 549,537 | Exempt: 22,453 | TRF Vol: 737,785 | Short Ratio: 74.5% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: TMDX — 55.1% short (0.4M / 0.8M)
Short: 446,522 | Exempt: 25,503 | TRF Vol: 809,924 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: TMDX — 59.0% short (0.3M / 0.5M)
Short: 302,735 | Exempt: 4,554 | TRF Vol: 513,058 | Short Ratio: 59.0% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_volume
Short Volume: TMDX — 59.3% short (0.9M / 1.5M)
Short: 896,760 | Exempt: 2,906 | TRF Vol: 1,513,092 | Short Ratio: 59.3% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_interest
FTD: TMDX — 18,854 shares ($1.4M) failed to deliver
Settlement: 20260507, Price: $72.92, FTD Value: $1,374,833.68, TRANSMEDICS GROUP INC COM